Clinical Usefulness of Transjugular Liver Biopsy in Patients With Hematological Diseases With Liver Dysfunction

Toru Ishikawa1, Erina Kodama2, Takamasa Kobayashi2

  • 1Department of Gastroenterology and Hepatology, Saiseikai Niigata Hospital, Niigata, JPN.

Cureus
|December 17, 2021
PubMed

Insights

Transjugular liver biopsy (TJLB) is crucial for diagnosing liver dysfunction in patients with hematological diseases when other methods fail. This study highlights TJLB

Area of Science:

  • Hepatology
  • Hematology
  • Interventional Radiology

Background:

  • Percutaneous liver biopsy is contraindicated in patients with hematological diseases and liver dysfunction.
  • Transjugular liver biopsy (TJLB) offers an alternative diagnostic method in these complex cases.
  • The clinical utility of TJLB for liver disorders in hematological patients requires further investigation.

Purpose of the Study:

  • To evaluate the clinical efficacy and diagnostic yield of Transjugular liver biopsy (TJLB).
  • To assess the role of TJLB in guiding therapeutic strategies for liver dysfunction in hematological patients.

Main Methods:

  • Retrospective analysis of 27 patients with hematological diseases and liver dysfunction requiring TJLB.
  • Review of clinical features and histological diagnoses obtained via TJLB.
  • Correlation of TJLB findings with subsequent treatment modifications.

Main Results:

  • TJLB successfully diagnosed various liver disorders, including drug-induced liver injury, nonalcoholic steatohepatitis, autoimmune hepatitis, and liver infiltration by underlying hematological diseases.
  • Specific diagnoses included drug-induced liver injury (n=8), liver infiltration (n=5), autoimmune hepatitis (n=3), nonalcoholic steatohepatitis (n=2), and others.
  • Therapeutic regimens were altered based on TJLB findings, demonstrating its clinical impact.

Conclusions:

  • Liver disorders in patients with hematological diseases have diverse etiologies.
  • Histological diagnosis via TJLB is essential for determining appropriate treatment strategies.
  • TJLB plays a vital role in managing complex liver dysfunction in hematological patients.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
16
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
548
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
15
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.4K
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
225